MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, VMD had -$4,039K decrease in cash & cash equivalents over the period. $11,931K in free cash flow.

Cash Flow Overview

Change in Cash
-$4,039K
Free Cash flow
$11,931K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Depreciation and amortization
    • Proceeds from sale of property a...
    • Net income
    • Others
Negative Cash Flow Breakdown
    • Purchase of property and equipme...
    • Cash paid for acquisitions, net ...
    • Shares repurchased under the sha...
    • Others

Cash Flow
2025-12-31
Net income
15,376
Depreciation and amortization
28,613
Stock-based compensation expense
9,132
Distributions of earnings received from equity method investments
0
Income from equity method investments
0
Loss (income) from debt investment
0
Loss (gain) on disposal of property and equipment
2,239
Amortization of deferred financing costs
228
Deferred income tax expense (benefit)
3,109
Accounts receivable, net
-1,158
Inventory
-59
Prepaid expenses and other assets
503
Trade payables
479
Deferred revenue
359
Accrued liabilities
255
Income tax payable/receivable
-4,110
Net cash provided by operating activities
51,916
Purchase of property and equipment
39,985
Investment in equity investments
0
Cash paid for acquisitions, net of cash acquired
26,332
Proceeds from sale of debt security
0
Proceeds from sale of property and equipment
16,151
Net cash used in investing activities
-50,166
Proceeds from exercise of options
1,439
Proceeds from term notes
9,000
Principal payments on term notes
730
Proceeds from revolving credit facilities
13,000
Principal payments on revolving credit facilities
13,000
Payments for debt issuance costs
115
Shares redeemed to pay income tax
1,734
Shares repurchased under the share repurchase program
13,225
Repayments of finance lease liabilities
50
Distributions to non-controlling interest
374
Net cash provided by (used in) financing activities
-5,789
Net increase (decrease) in cash and cash equivalents
-4,039
Cash and cash equivalents at beginning of year
17,540
Cash and cash equivalents at end of period
13,501
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Depreciation andamortization$28,613K Net income$15,376K Stock-based compensationexpense$9,132K Deferred income taxexpense (benefit)$3,109K Accounts receivable, net-$1,158K Trade payables$479K Deferred revenue$359K Accrued liabilities$255K Amortization of deferredfinancing costs$228K Inventory-$59K Net cash provided byoperating activities$51,916K Canceled cashflow$6,852K Net increase(decrease) in cash and cash...-$4,039K Canceled cashflow$51,916K Proceeds from sale ofproperty and equipment$16,151K Proceeds from revolvingcredit facilities$13,000K Proceeds from term notes$9,000K Proceeds from exercise ofoptions$1,439K Income taxpayable/receivable-$4,110K Loss (gain) ondisposal of property and...$2,239K Prepaid expenses andother assets$503K Net cash used ininvesting activities-$50,166K Canceled cashflow$16,151K Net cash provided by(used in) financing...-$5,789K Canceled cashflow$23,439K Purchase of property andequipment$39,985K Cash paid foracquisitions, net of cash...$26,332K Shares repurchasedunder the share...$13,225K Principal payments onrevolving credit...$13,000K Shares redeemed to payincome tax$1,734K Principal payments on termnotes$730K Distributions tonon-controlling interest$374K Payments for debtissuance costs$115K Repayments of finance leaseliabilities$50K

VIEMED HEALTHCARE, INC. (VMD)

VIEMED HEALTHCARE, INC. (VMD)